SARM S 22
STUDIES & RESEARCH
Our Medical Team is constantly engaging in research and development, and keeping up to date with the latest medical papers and clinical trials to inform our patients about the peptides we supply. Access the latest clinical studies relating to SARM S 22 below.
This peptide is a Selective Androgen Receptor Modulator and can be delivered through subcutaneous injection or transdermal cream. SARM S 22 is known to provide the benefits of muscle development, while minimising any negative side-effects that hormones or steroids are known to cause. This peptide works by selectively targeting androgen receptors in muscles and bones, for muscle development, without effecting hormone levels.